HCID21100270

{4-[5-(Butane-1-sulfonyl)-thiazol-2-yl]-piperazin-1-yl}-[5-methanesulfonyl-2-(2,2,2-trifluoro-ethoxy)-phenyl]-methanone

[4-(5-butylsulfonyl-1,3-thiazol-2-yl)piperazin-1-yl]-[5-methylsulfonyl-2-(2,2,2-trifluoroethoxy)phenyl]methanone

C21H26F3N3O6S3569.6 g/mol

IDENTITY

结构与身份

标准SMILES: CCCCS(=O)(=O)c1cnc(N2CCN(C(=O)c3cc(S(C)(=O)=O)ccc3OCC(F)(F)F)CC2)s1
InChIKey: RXEMJEGNDCXMME-UHFFFAOYSA-N
分子式: C21H26F3N3O6S3
平均分子量: 569.6 g/mol
单同位素质量: 569.09358356

COMPUTED

已同步

ALIASES

共 2 条

{4-[5-(Butane-1-sulfonyl)-thiazol-2-yl]-piperazin-1-yl}-[5-methanesulfonyl-2-(2,2,2-trifluoro-ethoxy)-phenyl]-methanoneSCHEMBL2828937

REACTIONS

2 条

Training data from https://doi.org/10.1039/C8SC04228D (3/10) · 10.1039/C8SC04228D

uspto-grants-2007_05 · 10.6084/m9.figshare.5104873.v1 · US07220744B2